Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.

Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.

<h4>Introduction</h4>The presence of rheumatism is well recognized in primary hypothyroidism. Dehydroepiandrstenedione sulphate (DHEAS) is associated with rheumatological diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This study aims to explore relationsh...

Full description

Bibliographic Details
Main Authors: Ravindra Shukla, Mayank Ganeshani, Monica Agarwal, Rakesh Jangir, Gaurav Kandel, Shrimanjunath Sankanagoudar, Shival Srivastava
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0246195

Internet

https://doi.org/10.1371/journal.pone.0246195

Similar Items